A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemotherapy Followed by Concurrent Platinum-Based Chemotherapy and 70 Gy Daily Radiotherapy: CALGB 30904-Reference-Cited by-同舟云学术

A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemotherapy Followed by Concurrent Platinum-Based Chemotherapy and 70 Gy Daily Radiotherapy: CALGB 30904

Published:2013-08 Issue:8 Volume:8 Page:1043-1049
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Salama Joseph K.,Hodgson Lydia,Pang Herbert,Urbanic James J.,Blackstock A. William,Schild Steven E.,Crawford Jeffrey,Bogart Jeffrey A,Vokes Everett E.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference21 articles.

1. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

2. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer;Schild;Int J Radiat Oncol Biol Phys,2004

3. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study;Jeremic;J Clin Oncol,1997

4. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide;Turrisi;N Engl J Med,1999

5. A meta-analysis of thoracic radiotherapy for small-cell lung cancer;Pignon;N Engl J Med,1992

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers;Current Oncology;2024-03-20

2. The Role of Thoracic Radiation Therapy Dosing in the Treatment of Limited-Stage Small Cell Lung Cancer: A Study Based on the National Cancer Database;Advances in Radiation Oncology;2022-09

3. Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-01-28

4. Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial;International Journal of Radiation Oncology*Biology*Physics;2021-10

5. Thoracic radiotherapy in small cell lung cancer—a narrative review;Translational Lung Cancer Research;2021-04